Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01768975 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee
A Phase 2 study, sponsored by Olatec Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
NCT01768975 is a Phase 2 study that has completed, run by Olatec Therapeutics. The registered enrollment target is 79 participants.
The verdict
NCT01768975, a Phase 2 study, has completed, sponsored by Olatec Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this trial is to investigate the efficacy and safety of OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
Interventions
- OTHER Placebo gel
- DRUG OLT1177 Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01768975
The ClinicalTrials.gov registry entry for NCT01768975 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olatec Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo gel is the first listed.
NCT01768975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01768975 about?
NCT01768975 is a clinical study titled "Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee". The purpose of this trial is to investigate the efficacy and safety of OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
What is the current status of trial NCT01768975?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2013-01. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01768975?
The interventions under investigation include: Placebo gel (OTHER), OLT1177 Gel (DRUG).
Who is sponsoring clinical trial NCT01768975?
This trial is sponsored by Olatec Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.